Document is current
Any future updates will be listed below
-
Authors
Rajakumar, Timothy https://orcid.org/0000-0002-0334-4349
Horos, Rastislav
Jehn, Julia
Schenz, Judith https://orcid.org/0000-0002-6771-8864
Muley, Thomas https://orcid.org/0000-0002-8141-0604
Pelea, Oana https://orcid.org/0000-0002-1968-9827
Hofmann, Sarah
Kittner, Paul
Kahraman, Mustafa
Heuvelman, Marco
Sikosek, Tobias https://orcid.org/0000-0001-9929-3525
Feufel, Jennifer
Skottke, Jasmin
Nötzel, Dennis
Hinkfoth, Franziska
Tikk, Kaja
Daniel-Moreno, Alberto
Ceiler, Jessika
Mercaldo, Nathaniel
Uhle, Florian
Uhle, Sandra
Weigand, Markus A.
Elshiaty, Mariam
Lusky, Fabienne
Schindler, Hannah
Ferry, Quentin
Sauka-Spengler, Tatjana https://orcid.org/0000-0001-9289-0263
Wu, Qianxin
Rabe, Klaus F.
Reck, Martin
Thomas, Michael
Christopoulos, Petros
Steinkraus, Bruno R. https://orcid.org/0000-0003-3757-1993
- License Information
-
More Information
Article History
Received: 14 October 2021
Accepted: 11 February 2022
First Online: 31 March 2022
Competing interests
: P.C. declares research funding from AstraZeneca, Novartis, Roche, Takeda, and advisory board/lecture/educational fees from AstraZeneca, Boehringer Ingelheim, Chugai, Kite, Novartis, Pfizer, Roche, and Takeda. M.R. reports receiving honoraria for lectures and consultancy from AstraZeneca, Amgen, BMS, Boehringer-Ingelheim, Lilly, Merck, MSD, Mirati, Novartis, Sanofi, Pfizer, Roche. K.F.R. reports payments or honoraria from Boehringer Ingelheim and Astra Zeneca, Novartis, Roche, Chiesi Pharmaceuticals, Regeneron, Sanofi and Berlin Chemie outside the submitted work. M.T. discloses honoraria from AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Celgene, Chugai, Lilly, MSD, Novartis, Pfizer, Roche, Takeda, Sanofi, Beigene, GSK and research funding from AstraZeneca, Bristol-Myers Squibb, Roche, and Takeda. T.R., R.H., J.J., S.H., P.K., M.K., M.H., T.S. J.F., J.Sk., D.N., A.D.M, J.C., and B.R.S. are employees of Hummingbird Diagnostics and hold company stock options. T.R., R.H., J.J., T.S., B.R.S. are inventors of patent applications related to response prediction fo immunotherapy submitted by Hummingbird Diagnostics. T.S.S. serves on the scientific advisory board of Hummingbird Diagnostics. N.M. received consulting fees from Hummingbird Diagnostics. The remaining authors declare no competing interests.
